REFERENCES. 4. Bottle A, Aylin P. Mortality associated with delay in operation after hip fracture: observational study. BMJ. 2006;332:

Preoperative Cardiac Evaluation. Preoperative Cardiac Evaluation Prior to Noncardiac Surgery

Prior to Noncardiac Surgery Carmine D Amico, D.O. Overview Learning objectives Introduction Procedure risk categorization Preoperative estimation of cardiac risk Stepwise approach to preoperative evaluation

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD

PERIOPERATIVE CARDIAC RISK ASSESSMENT Divya Gollapudi, MD Clinical Assistant Professor Hospital Medicine Program Division of General Internal Medicine Harborview Medical Center None Disclosures Objectives

Perioperative Laboratory and Cardiac Testing: What is Necessary? David L. Hepner, M.D. Brigham and Women s Hospital Harvard Medical School, Boston, MA

Session: L111 Session: L323 Perioperative Laboratory and Cardiac Testing: What is Necessary? David L. Hepner, M.D. Brigham and Women s Hospital Harvard Medical School, Boston, MA Disclosures: This presenter

Q: Do cardiac risk stratification indexes

1-MINUTE CONSULT ROHAN MANDALIYA, MD, FACP Clinical Fellow, Division of Gastroenterology and Hepatology, Department of Medicine, Georgetown University Hospital, Washington, DC GENO MERLI, MD, MACP Professor

Perioperative Management. Perioperative Management of Cardiovascular Medications

of Cardiovascular Medications Carmine D Amico, D.O. Overview Learning objectives Beta-blockers Statins Alpha-2 agonists Calcium channel blockers ACE inhibitors and ARB s Anticoagulants Antiplatelet agents

SESSION 5 2:20 3:35 pm

SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac

How can we identify the high-risk patient?

REVIEW C URRENT OPINION How can we identify the high-risk patient? Ashwin Sankar a, W. Scott Beattie a,b, and Duminda N. Wijeysundera a,b,c,d Purpose of review Accurate and early identification of high-risk

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

Update in perioperative cardiac medicine

REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will consider the findings of recent studies when caring for cardiac patients undergoing noncardiac surgery STEVEN L. COHN, MD, MS, FACP, SFHM Medical Director,

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

A meta-analysis of intraoperative factors associated with postoperative cardiac complications

A meta-analysis of intraoperative factors associated with postoperative cardiac complications Abstract Skinner DL, FCS(SA), Consultant Department of Surgery, University of Kwazulu-Natal Goga S, FCA(SA),

2010, Metzler Helfried

Perioperative Strategies in Patients on Dual Antiplatelet Drug Therapy: Noncardiac Surgery H. Metzler Department of Anaesthesiology and Intensive Care Medicine Medical University of Graz, Austria What

Perioperative Myocardial Infarction

Perioperative Myocardial Infarction Which patient should UNDERGO CORONARY ANGIOGRAPHY? The Cardiologists view Hans Rickli, St.Gallen 1 Experience Standards Risk stratification Team approach.. Tightrope

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

REFERENCES 1. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.

REFERENCES 1. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

Perioperative Myocardial Infarction in Noncardiac Surgery: Focusing on Intraoperative and Postoperative Risk Factors

Perioperative Myocardial Infarction in Noncardiac Surgery: Focusing on Intraoperative and Postoperative Risk Factors Cardiac Unit, Department of Medicine, Prapokklao Hospital, Chantaburi Abstract Perioperative

Preoperative Cardiac Evaluation:

Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical

Educational Objectives

E14 OCT 17 William J. Elliott, M.D., Ph.D. Peri-Operative Management of Hypertension: An Internist s Perspective Disclosure Statement The speaker s research and educational activities have been supported

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY WHICH PATIENT IS AT HIGHEST RISK? 1. 70 yo asymptomatic patient with history of heart failure

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with American Association for Thoracic Surgery, American

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2008 Update Plus Overview of the Guidelines Concept John Coyle, M.D. October 16, 2008 The History of Medicine As Mountaineering Feat

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting & Managing Cardiac Risk A 70-y.o. man with progressive

Preoperative cardiovascular assessment for noncardiac surgery: update of the guidelines

04RC1- de Hert Preoperative cardiovascular assessment for noncardiac surgery: update of the guidelines Stefan De Hert Department of Anesthesiology, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent,

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

Last Updated: Version 3.2 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure ID#: SCIP- Performance

History of Heart Failure is the Major Risk Factor in Coronary Patients Undergoing Abdominal Nonvascular Surgery

ISPUB.COM The Internet Journal of Anesthesiology Volume 22 Number 1 History of Heart Failure is the Major Risk Factor in Coronary Patients Undergoing Abdominal Nonvascular V Karapandzic, M Petrovic, M

Perioperative Infarcts: Epidemiology, predictors and post-op monitoring

Friday Nov 3rd, 2017 1pm Perioperative Infarcts: Epidemiology, predictors and post-op monitoring Dr Carol Chong Geriatrician Northern Health, Epping, Victoria, Australia How I became interested in this

Perioperative Medicine 2016 Some Answers, Even More Questions

Learning Objectives Perioperative Medicine 2016 Some Answers, Even More Questions Kurt Pfeifer, MD, FACP, FHM Professor of Medicine Medical College of Wisconsin Outline changes to the ACC/AHA perioperative

Supplementary Online Content

Supplementary Online Content Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand S-LT, Rumsfeld JS, Messenger JC, Yeh RW. Use of

Scope of the Problem: DAPT and Triple Therapy after Stenting

Scope of the Problem: DAPT and Triple Therapy after Stenting Kurt Huber, MD, FESC, FACC 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Session, August 30, 2010,

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only

Last Updated: Version 4.4a NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Voluntary Only Measure Set: Surgical Care Improvement Project (SCIP) Set

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation

Session 7: Cardiology I and II Answer Explanations

Session 7: Cardiology I and II Answer Explanations Cardiology I 1. Answer A: Intravenous heparin 4000-unit intravenous bolus, followed by a 1000-unit/hour continuous infusion. The NSTE-ACS guidelines recommend

Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery

1 Department of Medicine, Cardiovascular Imaging Center, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 2 Department of Emergency Medicine,

Keywords: Troponins; Vascular surgery; Cardiac risks; Tissue loss; Statins; Biomarkers; Outcomes

Journal of Critical Care (2012) 27, 66 72 Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery Troponins and postoperative

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS)

Original Article Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS) Alina Hua 1, Holly Pattenden 1, Maria Leung 1, Simon Davies

NIH Public Access Author Manuscript Ann Vasc Surg. Author manuscript; available in PMC 2014 July 01.

NIH Public Access Author Manuscript Published in final edited form as: Ann Vasc Surg. 2013 July ; 27(5): 646 654. doi:10.1016/j.avsg.2012.07.024. Contemporary outcomes in vascular patients who require

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL Guidelines in review: Comparison of the 2014 ACC/AHA guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac

Cardiac Complications in Patients Undergoing Major Noncardiac Surgery

The new england journal of medicine Review Article Dan L. Longo, M.D., Editor Cardiac Complications in Patients Undergoing Major Noncardiac Surgery P.J. Devereaux, M.D., Ph.D., and Daniel I. Sessler, M.D.

Risk stratification for non-cardiac surgery

Southern African Journal of Anaesthesia and Analgesia 2018; 24(3)(Supplement 1) Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0

Judicious Use of Preoperative Consultants. Relevant disclosures: None. Preoperative Consultation by Specialists: Overall Impact on Outcome?

Judicious Use of Preoperative Consultants Changing Practice of Anesthesia Meeting 2014 Relevant disclosures: None Rachel Eshima McKay, MD Professor, Anesthesia and Perioperative Director, UCSF Mount Zion

REPORTS FROM THE FIELD. A Clinical Pathway to Improve Surgical Risk Assessment and Use of Perioperative ß Blockade in Noncardiac Surgery Patients

A Clinical Pathway to Improve Surgical Risk Assessment and Use of Perioperative ß Blockade in ncardiac Surgery Patients Robert L. Robinson, MD, Laura Q. Rogers, MD, Christine Y. Todd, MD, and Robert C.

Pre-Operative Risk Assessment and Risk Reduction Before Surgery

Journal of the American College of Cardiology Vol. 51, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.03.005

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin

Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin Dr. Vikas Tandon Associate Professor, Cardiology

Myocardial injury after noncardiac surgery: an underappreciated problem and current challenges

REVIEW C URRENT OPINION Myocardial injury after noncardiac surgery: an underappreciated problem and current challenges Eckhard Mauermann a, Christian Puelacher b, and Giovanna Lurati Buse a Purpose of

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality Art Wallace, MD, PhD SF VAMC Chief of Anethesia and Vice Chair of Anesthesia and Perioperative Care UCSF

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory

Role of prophylactic coronary revascularisation in improving cardiovascular outcomes during non-cardiac surgery: A narrative review

Neth Heart J (2016) 24:563 570 DOI 10.1007/s12471-016-0871-1 REVIEW ARTICLE Role of prophylactic coronary revascularisation in improving cardiovascular outcomes during non-cardiac surgery: A narrative

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

Chest pain affects 20% to 40% of the general population during their lifetime.

Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a

Mario Plebani University-Hospital of Padova, Italy

Mario Plebani University-Hospital of Padova, Italy CK-MB mass assay CHF guidelines use BNP for rule out AST in AMI CK in AMI INH for CK-MB electrophoresis for CK and LD isoenzymes RIA for myoglobin WHO

A case of myocardial infarction caused by obstruction of a drug-eluting stent during the perioperative period

Toyama et al. JA Clinical Reports (2015) 1:22 DOI 10.1186/s4098101500252 CASE REPORT A case of myocardial infarction caused by obstruction of a drugeluting stent during the perioperative period Hiroaki

Is there still a place for beta-blockers in perioperative cardioprotection?

Is there still a place for beta-blockers in perioperative cardioprotection? 14 Michal Horacek Cardiovascular complications, such as hypertension or hypotension, myocardial infarction, left ventricular

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

Post Operative Troponin Leak: Does It Really Matter? David Smyth Christchurch New Zealand Life Was Simple Once Transmural Infarction Subendocardial Infarction But the Blood Tests Were n t Perfect Creatine

The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed?

Editorial Page 1 of 5 The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Regina Kayse, Richard C. Becker Division of Cardiovascular Health and

1. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study Hsieh, B.P., et al. Am

SCIP Cardiac Measure. Lee A. Fleisher, M.D.

SCIP Cardiac Measure Lee A. Fleisher, M.D. fleishel@uphs.upenn.edu Medicare Surgical Infection Prevention (SIP) Project Objective To decrease the morbidity and mortality associated with postoperative infection

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

Last Updated: Version 4.4 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Acute Myocardial Infarction (AMI) Set Measure I#: Performance Measure Name: Primary

Update in Perioperative Medicine Know When to Hold Em

Update in Perioperative Medicine Know When to Hold Em Kurt Pfeifer, MD, FACP Associate Professor of Medicine Medical College of Wisconsin Learning Objectives Cardiovascular risk Risk assessment Beta-blockers

Cardiac Risk Assessment in the Preoperative period

Cardiac Risk Assessment in the Preoperative period Catherine Curley, MD May, 2017 Disclosures I am not a cardiologist! 1 Case 1 78 yo man presenting to the ED after mechanical fall on his driveway. Found

A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery

Journal of the American College of Cardiology Vol. 49, No. 17, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.11.052

Value of troponin measurements in carotid artery revascularization

Value of troponin measurements in carotid artery revascularization Gert J de Borst Department of Vascular Surgery Postoperative myocardial infarction after NCS: Magnitude of the problem POISE-1: 367 /8,351=

Perioperative cardiovascular medicine: 5 questions for 2018

CME CREDIT REVIEW Perioperative cardiovascular medicine: 5 questions for 2018 ABSTRACT A MEDLINE search was performed from January 2017 to February 2018, and articles were selected for this update based

PERIOPERATIVE CARDIAC COMPLICATIONS are a

Revised Cardiac Risk Index (Lee) and Perioperative Cardiac Events as Predictors of Long-term Mortality in Patients Undergoing Endovascular Abdominal Aortic Aneurysm Repair Sylvia Archan, MD,* Christopher

Postoperative Bare-Metal Stent Thrombosis 37 Days after Percutaneous Coronary Intervention: A Case Report

ARC Journal of Anesthesiology Volume 1, Issue 2, 2016, PP 26-30 ISSN No. 2455-9792(Online) http://dx.doi.org/10.20431/2455-9792.0102005 www.arcjournals.org Postoperative Bare-Metal Stent Thrombosis 37

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI Interventional Cardiologist Cardiovascular Institute of the South Director of Cardiovascular Services St. Charles Parish

The original article was published by Elsevier in the. American Journal of Cardiology 2007;100(8): doi: /j.amjcard

- 1 - The original article was published by Elsevier in the American Journal of Cardiology 2007;100(8):1310-1313. doi:10.1016/j.amjcard.2007.05.058 And is available from: http://www.sciencedirect.com/science/journal/00029149

Outcomes in Heart Failure Patients After Major Noncardiac Surgery

Journal of the American College of Cardiology Vol. 44, No. 7, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.059

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

Hypertension and anesthesia Satoshi Hanada a, Hiromasa Kawakami a, Takahisa Goto b and Shigeho Morita a

Hypertension and anesthesia Satoshi Hanada a, Hiromasa Kawakami a, Takahisa Goto b and Shigeho Morita a Purpose of review There are still many controversies about perioperative management of hypertensive

Of the 25 million people in the United States who underwent

CASE-BASED REVIEW Reducing Perioperative Cardiac Complications in Patients Undergoing Noncardiac Surgery Case Study and Commentary, Darryl K. Potyk, MD The following article, Reducing Perioperative Cardiac

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

Advances in Antiplatelet Therapy in PCI and ACS Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland Targets for Platelet

Department of Anesthesiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Acta Med. Nagasaki 61: 27 31 Case Report MS#AMN 07196 A case of acute coronary syndrome during operation, resulting in ventricular fibrillation Osamu Yo s h i t o m i 1, Taiga Ic h i n o m i ya 1, Chiaki

2017 Update in perioperative medicine: 6 questions answered

REVIEW CME CREDIT LEARNING OBJECTIVE: Readers will apply current guidelines and evidence to the care of their perioperative patients RYAN MUNYON, MD Assistant Professor of Medicine, Penn State University;

Unfractionated Heparin during the Interruption of Antiplatelet Therapy for Non-cardiac Surgery after Drug-eluting Stent Implantation

ORIGINAL ARTICLE Unfractionated Heparin during the Interruption of Antiplatelet Therapy for Non-cardiac Surgery after Drug-eluting Stent Implantation Akihito Tanaka 1, Hideki Ishii 1, Yosuke Tatami 1,

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

Incremental Risk of Prior Coronary Arterial Stents for Pulmonary Resection

Incremental Risk of Prior Coronary Arterial Stents for Pulmonary Resection Felix G. Fernandez, MD, Traves D. Crabtree, MD, Jingxia Liu, PhD, and Bryan F. Meyers, MD, MPH Section of General Thoracic Surgery,

Dr Kerry Gunn. Dr Nicola Broadbent. Anaesthesiologist Auckland City Hospital Auckland. Specialist Anaesthetist Auckland City Hospital Auckland

Dr Kerry Gunn Anaesthesiologist Auckland City Hospital Auckland Dr Nicola Broadbent Specialist Anaesthetist Auckland City Hospital Auckland 8:30-9:25 WS #96: Optimising Patients for Surgery - Defining

The risk of non-cardiac surgery after

Review Article Hellenic J Cardiol 2011; 52: 141-148 Systematic Review of the Frequency and Outcomes of Non-Cardiac Surgery After Drug- Eluting Stent Implantation Laith I. Alshawabkeh 1, Subhash Banerjee

Perioperative myocardial infarction is a major cause of morbidity and mortality in patients who

Focused Issue of This Month Anesthesia for Noncardiac Surgery in the Patients with Cardiac Disease Kyung Yeon Yoo, MD Department of Anesthesiology and Pain Medicine, Chonnam National University College

Preoperative Cardiac Evaluation of Patients With Acute Hip Fracture

An Original Study Preoperative Cardiac Evaluation of Patients With Acute Hip Fracture Jonathan Cluett, MD, Jill Caplan, MD, and Warren Yu, MD Abstract The goals of the present study were to assess if there

adverse events (MACE) and all-cause mortality in patients with ischemic heart disease undergoing noncardiac surgery.

Research Original Investigation Association of β-blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery A Danish Nationwide

04RC1 The patient with coronary stents and antiplatelet agents: what to do?

04RC1 The patient with coronary stents and antiplatelet agents: what to do? H. Metzler Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Austria Saturday, June 6, 2009 13:00-13:45

Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery

Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery Santiago Garcia, MD, a Nicholas Marston, MD, a Yader Sandoval, MD, b Gordon Pierpont, MD, PhD, a Selcuk Adabag,

Updates & Controversies in Perioperative Medicine

Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Updates in Perioperative Medicine Estimating mortality in surgical

Review Article. Perioperative considerations in the management of a patient with coronary artery disease undergoing noncardiac surgery 1.

Review Article Vidarbha Journal of Internal Medicine Volume 19 July 2015 Perioperative considerations in the management of a patient with coronary artery disease undergoing noncardiac surgery 1 Tempe D

by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver

Perioperative Cases by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver 75 yo for left knee arthroplasty Problem List Social Hx: obesity uses a walker diabetes because of

Dr Αντώνιος Στ. Ντάτσιος MSc, MRCP(UK), FESC. Επεμβατικός Καρδιολόγος Επιμελητής Β Γ. Ν. Θ. Παπαγεωργίου

Dr Αντώνιος Στ. Ντάτσιος MSc, MRCP(UK), FESC. Επεμβατικός Καρδιολόγος Επιμελητής Β Γ. Ν. Θ. Παπαγεωργίου Θεσσαλονίκη, 9/2/2018 Disclosures: None Primary efficacy outcome* (%/year) Antiplatelet Therapy

Perioperative Management. Perioperative Management of Cardiovascular Medications

of Cardiovascular Medications Carmine D Amico, D.O. Overview Learning objectives Beta-blockers Statins Alpha-2 agonists Calcium channel blockers ACE inhibitors and ARB s Anticoagulants Antiplatelet agents

The How to Guide for Reducing Surgical Complications

The How to Guide for Reducing Surgical Complications Prevent Perioperative cardiovascular events Continue beta blockers for patients admitted on beta blockers Main contacts for Reducing Surgical Complications

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients

SYP.CLO-A.16.07.01 Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients dr. Hariadi Hariawan, Sp.PD, Sp.JP (K) TOPICS Efficacy Safety Consideration from Currently Available Antiplatelet Agents

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records.

Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Chest Pain (CP) Set Measure ID # OP-4 * OP-5 * Measure Short Name Aspirin at Arrival